I may be naive but I was wondering why GSK doesn't make a takeover offer for Biota. Surely that would solve the court case problems whilst getting control of Relenza.
This is NOT a rumour.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.